Judge: Investors Failed To Plead Falsity In Stock-Drop Case Against Drug Maker
SAN FRANCISCO — Shareholders in a securities class action lawsuit against a clinical-stage biopharmaceutical company and others failed to plead falsity in making their federal securities law claims, a federal judge...To view the full article, register now.
Already a subscriber? Click here to view full article